Mirae Asset Global Investments’s Fulgent Genetics FLGT Stock Holding History

Mirae Asset Global Investments’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-86,792	Closed	-$2.59M	–	1893
2024 Q1	$2.59M	Buy	86,792 +42,998	+98%	+$1.07M	0.01%	1074
2023 Q4	$1.27M	Sell	43,794 -59,588	-58%	-$1.59M	﹤0.01%	1492
2023 Q3	$2.76M	Buy	103,382 +8,601	+9%	+$294K	0.01%	1056
2023 Q2	$3.51M	Buy	94,781 +7,314	+8%	+$255K	0.01%	992
2023 Q1	$2.73M	Buy	87,467 +719	+0.8%	+$23.1K	0.01%	1055
2022 Q4	$2.58M	Sell	86,748 -22,072	-20%	-$790K	0.01%	1035
2022 Q3	$4.15M	Buy	108,820 +14,181	+15%	+$711K	0.01%	873
2022 Q2	$5.16M	Buy	+94,639	New	+$5.2M	0.01%	827

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mirae Asset Global Investments's FLGT Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 86,792 shares — an estimated $2.59M sold.

Mirae Asset Global Investments first reported a position in FLGT in Q2 2022 and held it in 8 quarters. The position peaked at $5.16M in Q2 2022. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

Mirae Asset Global Investments reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
Mirae Asset Global Investments sold 86,792 Fulgent Genetics shares in Q2 2024, an estimated $2.59M.
Mirae Asset Global Investments first reported a position in Fulgent Genetics in Q2 2022 and held it in 8 quarters.
Mirae Asset Global Investments's Fulgent Genetics position peaked at $5.16M in Q2 2022.
173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.